Additive effects on the energy barrier for synaptic vesicle fusion cause supralinear effects on the vesicle fusion rate

  1. Sebastiaan Schotten
  2. Marieke Meijer
  3. Alexander Matthias Walter
  4. Vincent Huson
  5. Lauren Mamer
  6. Lawrence Kalogreades
  7. Mirelle ter Veer
  8. Marvin Ruiter
  9. Nils Brose
  10. Christian Rosenmund
  11. Jakob B. Sørensen
  12. Matthijs Verhage
  13. Lennart Niels Cornelisse  Is a corresponding author
  1. VU University Medical Center, Netherlands
  2. Charité, Universitätsmedizin Berlin, Germany
  3. Max Planck Institute for Experimental Medicine, Germany
  4. University of Copenhagen, Denmark

Abstract

The energy required to fuse synaptic vesicles with the plasma membrane ('activation energy') is considered a major determinant in synaptic efficacy. From reaction rate theory we predict that a class of modulations exists, which utilize linear modulation of the energy barrier for fusion to achieve supralinear effects on the fusion rate. To test this prediction experimentally, we developed a method to assess the number of releasable vesicles, rate constants for vesicle priming, unpriming, and fusion, and the activation energy for fusion by fitting a vesicle state model to synaptic responses induced by hypertonic solutions. We show that ComplexinI/II deficiency or phorbol ester stimulation indeed affects responses to hypertonic solution in a supralinear manner. An additive versus multiplicative relationship between activation energy and fusion rate provides a novel explanation for previously observed non-linear effects of genetic/pharmacological perturbations on synaptic transmission and a novel interpretation of the cooperative nature of Ca2+-dependent release.

Article and author information

Author details

  1. Sebastiaan Schotten

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  2. Marieke Meijer

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  3. Alexander Matthias Walter

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  4. Vincent Huson

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  5. Lauren Mamer

    NeuroCure Cluster of Excellence, Charité, Universitätsmedizin Berlin, Berlin, Germany
    Competing interests
    No competing interests declared.
  6. Lawrence Kalogreades

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  7. Mirelle ter Veer

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  8. Marvin Ruiter

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  9. Nils Brose

    Department of Molecular Neurobiology, Max Planck Institute for Experimental Medicine, Göttingen, Germany
    Competing interests
    No competing interests declared.
  10. Christian Rosenmund

    NeuroCure Cluster of Excellence, Neuroscience Research Center, Charité, Universitätsmedizin Berlin, Berlin, Germany
    Competing interests
    Christian Rosenmund, Reviewing editor, eLife.
  11. Jakob B. Sørensen

    Department of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
  12. Matthijs Verhage

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  13. Lennart Niels Cornelisse

    Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Medical Center, Amsterdam, Netherlands
    For correspondence
    l.n.cornelisse@vu.nl
    Competing interests
    No competing interests declared.

Reviewing Editor

  1. Michael Häusser, University College London, United Kingdom

Publication history

  1. Received: November 7, 2014
  2. Accepted: April 13, 2015
  3. Accepted Manuscript published: April 14, 2015 (version 1)
  4. Version of Record published: May 12, 2015 (version 2)

Copyright

© 2015, Schotten et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,877
    Page views
  • 566
    Downloads
  • 35
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sebastiaan Schotten
  2. Marieke Meijer
  3. Alexander Matthias Walter
  4. Vincent Huson
  5. Lauren Mamer
  6. Lawrence Kalogreades
  7. Mirelle ter Veer
  8. Marvin Ruiter
  9. Nils Brose
  10. Christian Rosenmund
  11. Jakob B. Sørensen
  12. Matthijs Verhage
  13. Lennart Niels Cornelisse
(2015)
Additive effects on the energy barrier for synaptic vesicle fusion cause supralinear effects on the vesicle fusion rate
eLife 4:e05531.
https://doi.org/10.7554/eLife.05531

Further reading

    1. Neuroscience
    Utsav Gyawali, David A Martin ... Donna Calu
    Research Article

    Midbrain and striatal dopamine signals have been extremely well characterized over the past several decades, yet novel dopamine signals and functions in reward learning and motivation continue to emerge. A similar characterization of real-time sub-second dopamine signals in areas outside of the striatum has been limited. Recent advances in fluorescent sensor technology and fiber photometry permit the measurement of dopamine binding correlates, which can divulge basic functions of dopamine signaling in non-striatal dopamine terminal regions, like the dorsal bed nucleus of the stria terminalis (dBNST). Here, we record GRABDA signals in the dBNST during a Pavlovian lever autoshaping task. We observe greater Pavlovian cue-evoked dBNST GRABDA signals in sign-tracking (ST) compared to goal-tracking/intermediate (GT/INT) rats and the magnitude of cue-evoked dBNST GRABDA signals decreases immediately following reinforcer-specific satiety. When we deliver unexpected rewards or omit expected rewards, we find that dBNST dopamine signals encode bidirectional reward prediction errors in GT/INT rats, but only positive prediction errors in ST rats. Since sign- and goal-tracking approach strategies are associated with distinct drug relapse vulnerabilities, we examined the effects of experimenter-administered fentanyl on dBNST dopamine associative encoding. Systemic fentanyl injections do not disrupt cue discrimination but generally potentiate dBNST dopamine signals. These results reveal multiple dBNST dopamine correlates of learning and motivation that depend on the Pavlovian approach strategy employed.